Streetbeat News

Stock Prices

JANX

Janux Therapeutics is reportedly considering a sale, leading to an increase in its stock price.

Portfolio Pulse from Benzinga Newsdesk

April 10, 2024 | 7:07 pm

ALPN

NVS

Alpine Immune Sciences Inc (NASDAQ:ALPN) is exploring strategic options, including a potential sale, due to interest from buyers. The company's stock has risen over 400% in the past year, partly due to promising clinical data on povetacicept for autoimmune glomerulonephritis. Novartis AG (NASDAQ:NVS) acquired Chinook Therapeutics last year, highlighting the growing interest in kidney disease treatments.

Portfolio Pulse from Vandana Singh

April 10, 2024 | 7:07 pm

GEV

GE Vernova shares are trading higher following its spinoff from GE Aerospace, indicating a positive market reception to the newly independent entity.

Portfolio Pulse from Benzinga Newsdesk

April 10, 2024 | 7:06 pm

FILUSD

Filecoin (CRYPTO: FIL) has seen a decrease of 3.79% in its price over the last 24 hours, now at $8.38, continuing a downward trend from the previous week. The trading volume has decreased by 7.0%, while the circulating supply has increased by 1.11%, now at 535.14 million, which is 27.29% of its max supply. Filecoin's market cap ranking is currently #28, with a value of $4.50 billion.

Portfolio Pulse from Benzinga Insights

April 10, 2024 | 7:03 pm

STXUSD

Stacks (CRYPTO: STX) has seen a 4.75% decrease in price over the last 24 hours, continuing a negative trend with a 0.0% loss over the past week. The trading volume for STX has decreased by 38.0%, and its circulating supply has slightly decreased by 0.17%, now at 1.45 billion. The current market cap for STX is ranked #29 at $4.45 billion.

Portfolio Pulse from Benzinga Insights

April 10, 2024 | 7:02 pm

UNIUSD

Uniswap (CRYPTO: UNI) has seen a 7.94% decrease in price over the last 24 hours, now at $10.29, despite a 3.0% increase over the past week. Trading volume has decreased by 37.0%, with the circulating supply remaining stable. UNI's market cap ranking is now #20 at $7.90 billion.

Portfolio Pulse from Benzinga Insights

April 10, 2024 | 7:01 pm

STWD

Four analysts have recently shared their views on Starwood Prop Trust (NYSE:STWD), with sentiments ranging from bullish to indifferent. Over the past three months, there has been a shift towards more positive ratings, with three somewhat bullish and one indifferent rating currently. The 12-month price targets suggest a stable outlook with an average target of $20.88. Analyst actions include both raises and lowers in ratings and price targets, reflecting changing market dynamics and company performance. Starwood Prop Trust, a real estate investment trust, has shown a revenue growth of 19.03% but lags in net margin and ROE compared to industry averages.

Portfolio Pulse from Benzinga Insights

April 10, 2024 | 7:01 pm

CPRT

Over the past 15 years, Copart (NASDAQ:CPRT) has delivered an average annual return of 25.05%, outperforming the market by 12.44% annually. A $100 investment in CPRT 15 years ago would be worth $2,970.71 today, showcasing the impact of compounded returns on investment growth. Copart's current market capitalization stands at $53.71 billion.

Portfolio Pulse from Benzinga Insights

April 10, 2024 | 7:00 pm

APLS

Apellis Pharmaceuticals (NASDAQ:APLS) has significantly outperformed the market with an annualized return of 24.08% over the past 5 years, turning a $1000 investment into $2,958.46 today. The company now has a market capitalization of $6.65 billion.

Portfolio Pulse from Benzinga Insights

April 10, 2024 | 7:00 pm

SHAK

Analysts have varied opinions on Shake Shack (NYSE:SHAK), with recent ratings ranging from bullish to bearish. The average 12-month price target has risen to $106.06, up 21.61% from $87.21. Analyst actions include maintaining, raising, and adjusting price targets, reflecting changing market dynamics and company performance. Shake Shack's financial performance shows solid revenue growth of 20.0% as of December 31, 2023, a net margin of 2.52%, but below-average ROE and ROA, indicating potential efficiency challenges.

Portfolio Pulse from Benzinga Insights

April 10, 2024 | 7:00 pm